FDA: Class I recall of Alaris Infusion Sets
Editor's Note The Food & Drug Administration (FDA) on July 18 identified the recall by Becton Dickinson of its Alaris Infusion Sets for the Alaris Pump Model 8100 as Class I, the most serious. The recall was initiated because of the potential for tube collapse that may cause unintended or…
FDA: Class I recall of Neonatal ConchaSmart Breathing Circuit
Editor's Note The Food & Drug Administration (FDA) on July 17 identified the recall by Teleflex of its Neonatal ConchaSmart Breathing Circuit with Dual Heated Limb and ConchaSmart Column as Class I, the most serious. The recall was initiated because of complaints of cracks in the swivel wye adaptors, which…
CDC: Drug overdose mortality drops for the first time in 20 years
Editor's Note The US drug overdose mortality rate dropped 5.1% to 68,557 deaths last year, compared with 72,224 in 2017, the Centers for Disease Control & Prevention (CDC) reported on July 17. It’s the first time overdose mortality has declined since 1999. The CDC noted that the death counts are…
Hospital network participation not linked with improved outcomes, lower costs
Editor's Note Hospital network participation was not associated with improvements in surgical outcomes or Medicare expenditures, compared with hospitals not in a network, this study finds. In this analysis of nearly 2 million Medicare beneficiaries having general, vascular, cardiac, or orthopedic surgery between 2007 and 2014 at network (1,868) or…
FDA: Class I recall of Hamilton–G5 Ventilators
Editor's Note The Food & Drug Administration on July 12 identified the recall by Hamilton Medical AG (Bonaduz, Switzerland) of its Hamilton-G5 Ventilators as Class I, the most serious. The recall was initiated because of a software failure that stops the ventilators after displaying an error message, leaving patients to…
You may also be interested in these sessions at the OR Manager Conference this September in Nashville, TN
The Road to Zero! Meeting Compliance After TJC Survey Using the SAFER Matrix
After this session you’ll be able to: Explain the SAFER Matrix used by The Joint Commission (TJC)., Discuss how to assess risk using mitigation strategies for compliance to the SAFER Matrix., Identify tools for creating and implementing required corrective action plans., Why this is important: The SAFER Matrix has been…
House to vote on repeal of ACA’s tax on high-cost insurance plans
Editor's Note House Leaders will vote the week of July 15 on a measure to repeal the Affordable Care Act’s 40% tax on high-cost healthcare insurance plans, the July 12 Bloomberg Tax reports. The measure is expected to have wide bipartisan support. Democrat Rep Joe Courtney of Connecticut is the…
Disadvantaged neighborhoods linked to higher readmission rates
Editor's Note Residing in a disadvantaged neighborhood in Maryland and being discharged from a hospital serving a large proportion of disadvantaged neighborhoods were independently associated with increased risk of readmission in this study. 2015 data from Maryland hospitals showed a 14.1% 30-day readmission rate for patients living in neighborhoods in…
CMS penalty program not linked to hospital safety improvements
Editor's Note The Centers for Medicare and Medicaid Services (CMS) hospital penalization in the Hospital Acquired Condition Reduction Program (HACRP) was not associated with significant changes in rates of hospital acquired conditions (HACs), 30-day readmissions, or 30-day mortality and does not appear to drive meaningful clinical improvements, this study finds.…
HHS forms group to streamline quality programs
Editor's Note The Department of Health and Human Services (HHS) announced on July 9 that it has formed a summit of key industry stakeholders and government leaders to provide insight as the Trump administration seeks to streamline, improve, and align measures used across federal healthcare quality programs. The Quality Summit,…
FDA: Class I recall of Edwards Lifesciences’ IntraClude Intra-Aortic Occlusion Device
Editor's Note The Food and Drug Administration on July 1 identified the recall by Edwards Lifesciences (Irvine, California) of its IntraClude Intra-Aortic Occlusion Device as Class I, the most serious. The recall was initiated because of a risk of balloon rupture during use in patients undergoing cardiopulmonary bypass. The company…
You may also be interested in these sessions at the OR Manager Conference this September in Nashville, TN
2019 Update on Sterilization & Disinfection Standards
After this session you’ll be able to: Describe new changes to sterilization standards and guidelines., Discuss high non-compliance areas related to sterilization and disinfection., Identify how these changes can be incorporated into departmental procedures., Why this is important: With the increased complexity in medical devices that comes with advanced research,…
